You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Details for Patent: 9,561,236

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,561,236 protect, and when does it expire?

Patent 9,561,236 protects BYFAVO and is included in one NDA.

This patent has twenty-one patent family members in sixteen countries.

Summary for Patent: 9,561,236

Title:	Dosing regimen for sedation with CNS 7056 (Remimazolam)
Abstract:	The invention relates to a dosing regimen for sedation with the fast-acting benzodiazepine CNS 7056 in combination with an opioid, in particular fentanyl, whereas CNS 7056 is given in a dose of 2 to 20 mg, preferably between 4 and 9 mg and most preferably between 5 and 8 mg.
Inventor(s):	Wilhelm-Ogunbiyi; Karin (Simmerath, DE), Borkett; Keith (Houghton Camps, GB), Tilbrook; Gary Stuart (Huntingdon, GB), Wiltshire; Hugh (Digswell, GB)
Assignee:	PAION UK LTD. (Cambridge, GB)
Application Number:	13/883,935
Patent Claim Types: see list of patent claims	Use; Delivery;

Drugs Protected by US Patent 9,561,236

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Acacia	BYFAVO	remimazolam besylate	POWDER;INTRAVENOUS	212295-001	Oct 6, 2020		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				USE OF REMIMAZOLAM FOR INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION IN ADULTS UNDERGOING PROCEDURES LASTING 30 MINUTES OR LESS	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,561,236

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	10014366	Nov 8, 2010
	10014784	Nov 19, 2010
	10014819	Nov 22, 2010
	10014972	Nov 25, 2010

PCT Information
PCT Filed	November 07, 2011	PCT Application Number:	PCT/EP2011/005581
PCT Publication Date:	May 18, 2012	PCT Publication Number:	WO2012/062439

International Family Members for US Patent 9,561,236

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2011328497	⤷ Try a Trial
China	103347519	⤷ Try a Trial
Denmark	2637662	⤷ Try a Trial
Eurasian Patent Organization	024926	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.